Enzon Pharms Inc (ENZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ENZN | AZN | AMGN | GILD | BMY |
| Company | Enzon Pharms Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | OTC US | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 0.0644 | 199.40 | 375.18 | 146.32 | 61.80 |
| High | 0.0644 | 199.52 | 377.09 | 146.75 | 62.00 |
| Low | 0.0606 | 195.26 | 361.40 | 143.35 | 60.26 |
| Latest | 0.0606 | 196.02 | 363.75 | 144.23 | 60.64 |
| Change | -0.0020 | -5.51 | -15.52 | -3.99 | -1.69 |
| % Change | -3.19% | -2.73% | -4.09% | -2.69% | -2.71% |
| Volume | 600 | 1,801,991 | 1,420,227 | 2,841,239 | 6,921,829 |
| 20-Day Average Volume | 77,660 | 2,389,776 | 2,749,780 | 7,639,624 | 13,503,154 |
| Previous Close | 0.0626 | 201.53 | 379.27 | 148.22 | 62.33 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.0655 | 201.98 | 375.80 | 150.06 | 60.95 |
| 20-Day Raw Stochastic | 27.50% | 33.56% | 3.25% | 5.92% | 55.26% |
| 20-Day Relative Strength | 49.85 | 49.29 | 50.10 | 51.70 | 57.60 |
| Weighted Alpha | -66.06 | +32.05 | +19.24 | +30.66 | +13.22 |
| Today's Opinion | 32% Sell | 80% Buy | 80% Buy | 88% Buy | 88% Buy |
| Previous Opinion | 32% Sell | 88% Buy | 100% Buy | 88% Buy | 100% Buy |
| Last Month's Opinion | 8% Buy | 72% Buy | 100% Buy | 100% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +9.58% since 02/25/26 | -4.23% since 02/26/26 | -4.57% since 02/26/26 | +0.11% since 02/26/26 | -0.65% since 02/26/26 |
| Low | 0.0600 on 02/26/26 | 195.26 on 03/05/26 | 361.81 on 03/05/26 | 143.35 on 03/05/26 | 60.26 on 03/05/26 |
| High | 0.0650 on 02/26/26 | 209.93 on 02/27/26 | 391.29 on 03/02/26 | 150.77 on 03/02/26 | 62.89 on 03/02/26 |
| 1-Month | |||||
| %Chg | -18.11% since 02/04/26 | +4.38% since 02/05/26 | -1.58% since 02/05/26 | -3.64% since 02/05/26 | +1.98% since 02/05/26 |
| Low | 0.0551 on 02/25/26 | 187.06 on 02/09/26 | 361.00 on 02/11/26 | 143.09 on 02/26/26 | 59.23 on 02/19/26 |
| High | 0.0751 on 02/05/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 3-Month | |||||
| %Chg | +38.36% since 12/04/25 | +8.31% since 12/05/25 | +9.73% since 12/05/25 | +18.73% since 12/05/25 | +16.40% since 12/05/25 |
| Low | 0.0310 on 12/30/25 | 178.08 on 01/21/26 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 50.33 on 12/10/25 |
| High | 0.0790 on 02/02/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | -35.74% since 09/04/25 | +19.55% since 09/05/25 | +27.62% since 09/05/25 | +25.10% since 09/05/25 | +28.77% since 09/05/25 |
| Low | 0.0310 on 12/30/25 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 0.0898 on 09/05/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 4,497 | 312,554,496 | 204,452,320 | 184,003,424 | 126,933,432 |
| Shares Outstanding, K | 74,215 | 1,550,908 | 539,068 | 1,241,421 | 2,036,474 |
| Annual Sales | 30,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | 780,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -820,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 0.20 | 0.32 | 0.45 | 0.37 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.02 on 11/12/25 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 05/08/26 | 05/05/26 | 05/07/26 | 04/23/26 | 04/23/26 |
| Most Recent Dividend | 0.240 on 09/30/19 | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | 09/30/19 | 02/20/26 | 02/13/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 22.03 | 17.25 | 18.14 | 9.95 |